| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 0 | 31.160 | 62.803 | 34.463 | 29.302 | 21.912 | 26.129 | 29.777 |
| Total Income - EUR | - | - | 0 | 34.964 | 68.399 | 40.002 | 34.519 | 26.669 | 30.467 | 33.768 |
| Total Expenses - EUR | - | - | 1.066 | 29.400 | 52.350 | 56.570 | 43.723 | 33.721 | 36.009 | 31.059 |
| Gross Profit/Loss - EUR | - | - | -1.066 | 5.564 | 16.049 | -16.568 | -9.203 | -7.052 | -5.542 | 2.709 |
| Net Profit/Loss - EUR | - | - | -1.066 | 5.086 | 15.418 | -16.916 | -9.926 | -7.541 | -5.607 | 2.653 |
| Employees | - | - | 0 | 2 | 3 | 3 | 1 | 1 | 1 | 0 |
Check the financial reports for the company - Criolife Terapy Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 0 | 33.549 | 28.115 | 31.595 | 20.937 | 15.614 | 10.553 | 6.153 |
| Current Assets | - | - | 15 | 13.067 | 28.569 | 10.420 | 9.728 | 6.488 | 6.491 | 6.588 |
| Inventories | - | - | 0 | 0 | 0 | 17 | 0 | 0 | 0 | 0 |
| Receivables | - | - | 0 | 4.867 | 24.771 | 10.256 | 9.671 | 6.427 | 6.178 | 6.138 |
| Cash | - | - | 15 | 8.200 | 3.798 | 148 | 56 | 60 | 313 | 450 |
| Shareholders Funds | - | - | -1.023 | 4.082 | 19.463 | 2.178 | -7.797 | -15.362 | -20.923 | -18.153 |
| Social Capital | - | - | 44 | 43 | 84 | 83 | 81 | 81 | 81 | 80 |
| Debts | - | - | 1.037 | 3.682 | 4.379 | 13.465 | 17.567 | 19.666 | 23.948 | 20.902 |
| Income in Advance | - | - | 0 | 40.571 | 34.528 | 28.026 | 22.511 | 19.419 | 15.022 | 10.989 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8695 - 8695" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Criolife Terapy Srl